N/A
Completed N=21
Auricular Acupressure as a Non-Opioid Adjuvant in Opioid Tolerant Patients
Source: ClinicalTrials.gov NCT05711537 ↗Enrolled (actual)
21
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcomePrimary: Pain Scores Using Numerical Rating Scale (NRS) — 6.62 score on a scale
Summary
The purpose of this study is to determine if the addition of auricular acupressure to the typical pharmacological regimen given to patients on the chronic pain/addiction service will lower pain scores and decrease pain medication usage.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Scores Using Numerical Rating Scale (NRS) |
6.68 | — |
| PRIMARY Pain, Enjoyment and General Activity (PEG) Assessment Scores |
6.5; 5.89; 6.44 | — |
| PRIMARY Visual Analogue Scale (VAS) |
70.05 | — |
| SECONDARY Changes in Amount of Opioid Use |
84.95; 67.34; 71.01; 53.16 | — |
| SECONDARY Willingness to Decrease Dependence Scores |
15.79; 26.32; 21.05; 36.84 | — |
| SECONDARY Generalized Anxiety Disorder (GAD-7) Score Changes |
10.9; 9.53 | — |
| SECONDARY Pain Catastrophizing Scale (PCS) Assessments |
23.15; 24.82 | — |
| SECONDARY Auricular Acupressure Acceptability-DAY 3-Satisfaction |
21.05; 21.05; 47.4; 10.5 | — |
| SECONDARY Auricular Acupressure Acceptability--DAY 3-future Use |
15.8; 31.6; 52.6 | — |
| SECONDARY Change in Patient Global Impression of Change (PGIC) Scores |
3.33; 3.22 | — |
| SECONDARY Changes in Patient-Reported Outcomes Measurement Information System (PROMIS) |
21.85; 17.89 | — |
Eligibility Criteria
Inclusion Criteria
- Age > or equal to 18
- History of documented chronic pain with or without opioid use disorder (Polysubstance abuse or opioid use disorder or opioid narcotic use documented as home medication)
- Estimated length of stay (admission) at least 5 days at the time of recruitment
- Able to read and understand informed consent form
Exclusion Criteria
- Patient refusal
- Patients with a known history of leaving against medical advice (AMA)
- only English-speaking participants will be eligible.
- Inability to communicate via telephone
- Participants with a history of skin disease (e.g., psoriasis) involving the ear, adhesive allergy, recent scar tissue on ear, or current abrasions or cuts on ear,
- Cognitive impairment (delirium, dementia)
- Physical impairment preventing them from applying pressure to the beads
- Patients with cardiac pacemakers (contraindication to POINTER PAL)
- Use of some types of hearing aids (obstructing the placement of beads)
- Any chronic or acute illness or psychiatric conditions that would impact adherence to the study requirements
Data sourced from ClinicalTrials.gov (NCT05711537). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.